Novartis Signs $1.4B Orionis Collaboration
June 10, 2026
Novartis has struck a second deal with Orionis Biosciences worth up to $1.4 billion to pursue difficult drug targets.
June 10, 2026
Novartis has struck a second deal with Orionis Biosciences worth up to $1.4 billion to pursue difficult drug targets.